Immuno-Biological Laboratories Co Ltd
TSE:4570
Immuno-Biological Laboratories Co Ltd
Operating Income
Immuno-Biological Laboratories Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Immuno-Biological Laboratories Co Ltd
TSE:4570
|
Operating Income
¥50.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Operating Income
¥5.5B
|
CAGR 3-Years
30%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Medinet Co Ltd
TSE:2370
|
Operating Income
-¥1.4B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-4%
|
|
CellSource Co Ltd
TSE:4880
|
Operating Income
¥1.2B
|
CAGR 3-Years
43%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Operating Income
¥1.2B
|
CAGR 3-Years
50%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
4%
|
|
WDB coco Co Ltd
TSE:7079
|
Operating Income
¥1.1B
|
CAGR 3-Years
32%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
See Also
What is Immuno-Biological Laboratories Co Ltd's Operating Income?
Operating Income
50.2m
JPY
Based on the financial report for Dec 31, 2023, Immuno-Biological Laboratories Co Ltd's Operating Income amounts to 50.2m JPY.
What is Immuno-Biological Laboratories Co Ltd's Operating Income growth rate?
Operating Income CAGR 1Y
51%
Over the last year, the Operating Income growth was 51%.